基于生物活性玻璃的核心外纳米粒子:用于控制药物释放和生物医学应用的多功能平台
Arthur M Gabriel1,2, Andrada-Ioana Damian-Buda1, Fernanda M Brugnari2
1Institute of Biomaterials, University of Erlangen-Nuremberg, 91058, Erlangen, Germany.
Materials today. Bio
|January 9, 2026
概括
核心外纳米粒子与生物活性玻璃核心提供先进的生物医学应用. 这些工程纳米材料为下一代疗法提供可调节的药物释放和增强的生物性能.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 材料化学 材料化学
背景情况:
- 核心外纳米粒子是生物医学应用中精确控制的多功能平台.
- 生物活性玻璃由于生物活性和治疗性离子释放,比具有优势.
研究的目的:
- 综合审查具有生物活性玻璃芯的核心外纳米结构.
- 分析外材料的可控释放和生物性能.
主要方法:
- 讨论了生物活性玻璃纳米粒子的组成和合成.
- 评估了用于物理化学作用的无机和聚合物外材料.
- 探讨了临床实施的挑战和未来方向.
主要成果:
- 体材料调节药物的扩散,稳定性,降解和向.
- 生物活性玻璃核心外结构为量身定制的疗法提供可调节的特性.
- 无机,天然和合成聚合物外提供了多功能工程选择.
结论:
- 核心生物活性玻璃纳米颗粒代表了先进生物医学疗法的可定制策略.
- 表面工程整合了用于下一代处理的结构功能.
- 解决在体内测试和临床翻译方面的挑战对于实施至关重要.
相关概念视频
Drug Delivery: Overview
718
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
718
Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
In Vitro Drug Release Testing: Overview, Development and Validation
302
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
302
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193


